GTC Biotherapeutics to Webcast Corporate Presentation at the G5 - ThinkEquity Partners' Fifth Annual Growth Conference

12 Sep 2007

·www.biospace.com

FRAMINGHAM, Mass.--(BUSINESS WIRE)--GTC Biotherapeutics, Inc. (“GTC”, Nasdaq: GTCB) announced today that Geoffrey Cox, Ph.D., GTC’s Chairman and CEO, is scheduled to present on Tuesday, September 18, 2007 at 10:00 a.m. during the G5 – ThinkEquity Partners’ Fifth Annual Growth Conference. The conference is being held at the St. Regis Hotel in San Francisco, California from September 17 - 20, 2007.

Organizations

GTC Biotherapeutics UK Ltd.

rEVO Biologics, Inc.

Indications

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.